Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
In Vivo (Athens, Greece)|November 4, 2020
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast CancerIveta Kolarova, Ladislav Dusek, Ales Ryska, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 15, 2015
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumabOndrej Fiala, Tomas Buchler, Beatrice Mohelnikova-Duchonova, et al.
Oncotarget|January 7, 2016
Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeAlessio Naccarati, Fabio Rosa, Veronika Vymetalkova, et al.
Cancer Management and Research|August 6, 2020
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 PatientsAlena Novakova-Jiresova, Katerina Kopeckova, Ludmila Boublikova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2013
Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs bindingBarbara Pardini, Fabio Rosa, Elisa Barone, et al.
Mutagenesis|October 20, 2017
MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosisMichaela Schneiderova, Alessio Naccarati, Barbara Pardini, et al.
Carcinogenesis|December 15, 2020
Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancerPetra Bendova, Barbara Pardini, Simona Susova, et al.
Cancers|September 9, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 StudyAlessandro Rizzo, Veronica Mollica, Andrea Marchetti, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapseMarta Krejci, Vlastimil Scudla, Elen Tothova, et al.
Anticancer Research|December 27, 2017
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 PatientsAlexandr Poprach, Ondrej Fiala, Renata Chloupkova, et al.
Pageof 14